Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2013-05-31
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary hypothesis 1: Subjects treated with hypnosis will report better sleep quality and fewer symptoms of Post Traumatic Stress Disorder (PTSD).
Secondary Hypothesis 2: Subjects treated with hypnosis will require less escalation of the gabapentin doses and have lower average pain scores than those in the control group.
Exploratory Hypothesis: Subjects who will randomize to the hypnosis treatment group early after injury will report lower rates of neuropathic pain and itch than subjects who will be enrolled in the study and receive hypnosis later in the healing process.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
BEnefit of HYpnosis on Pain During Stitches in Emergency Room
NCT06497712
Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis
NCT01944150
The Effect of Healing Touch on Sleep Patterns of Pediatric Burn Patients
NCT01983280
Interest of Hypnosis on Pain Management During a Guided Echo Infiltration of the Hand
NCT04328623
Effect of Two Acupuncture Protocols on Vulvodynia
NCT03481621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Control subjects will receive treatment as usual, which consists of a standardized protocol for treating post-burn itch. This protocol is based on past research and combines medications in a stepped approach that establishes therapeutic decisions based on clearly defined criteria.
Subjects randomized to the experimental group will undergo four sessions of live hypnosis completed over a two month period. They will be provided with a Compact Disk (CD) of each session and instructed to listen to it daily. Post-hypnotic suggestions will address uncomfortable sensations, with additional suggestions for improved sleep and well-being. Subjects may be inpatient or outpatients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Care
Subjects in this condition will receive our standard care for itch, which includes a stepped based algorithm of medications.
Standard of Care
Hypnosis Condition
Subjects in this condition will receive standard care plus the addition of 4 sessions of hypnosis delivered over a two month period.
Hypnosis
Patients in this group will receive standard care plus 4 sessions of hypnosis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hypnosis
Patients in this group will receive standard care plus 4 sessions of hypnosis.
Standard of Care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to provide informed consent for study participation
* ability to read and understand English
* Undergoing pharmacologic therapy for burn related itch according to the standard itch protocol
* Scoring of 4 out of 10 on the Numerical Rating Scale for average itch or pain
Exclusion Criteria
* Inability to provide informed consent
* Inability to read or understand English
* Delirium
* History of mania, paranoia, dissociation and current suicidal ideation
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shelley A. Wiechman
Associate Professor, Rehabilitation Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harborview Medical Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00000542
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.